LINC02650

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, LINC02650 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated LINC02650 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC02650 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02650 expression acts as an unfavorable survival marker.

READ, LIHC, and KIRP are the cancer types where LINC02650 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
READDFSTertileAll0.1770.824<.00172view →
LIHCDFSTertileAll0.0630.555<.00154view →
KIRPOSTertileAll0.5800.903<.00136view →
STADDFSTertileAll0.1520.535.00224view →
BRCAOSTertileAll0.1590.578.04712view →
PCPGDFSTertileAll0.0860.846.0019view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LINC02650–READ (DFS)

Kaplan–Meier survival curve for LINC02650 RNA-high vs -low samples in READ.

Open the READ breakdown →

Exploration